Market Research Logo

Russia Pharmaceuticals and Healthcare Report Q2 2015

Russia Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Given the depreciation of the rouble, we expect price rises and drug supply concerns to force the government to further intervene in the pharmaceutical market over the course of 2015. Despite the volatility of the Russian rouble and the considerable operating risks in the country, we believe that multinational pharmaceutical companies will remain committed to operating and investing in the country's pharmaceutical market, given the underlying disease burden in the country, the large absolute size of the pharmaceutical market and the expected growth in pharmaceutical consumption.

Headline Expenditure Projections

Pharmaceuticals: RUB879.67bn (USD22.80bn) in 2014 to RUB999.93bn (USD16.00bn) in 2015; +13.7% in local currency terms and -29.8% in US dollar terms.

Healthcare: RUB4.81trn (USD124.75bn) in 2014 to RUB5.240bn (USD83.84bn) in 2015; 8.9% in local currency terms and -32.8% in US dollar terms.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Russia 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Russia 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Russia 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Russia 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Russia 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Russia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Russia 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: GDP By Expenditure (Russia 2012-2019)
Industry Risk Reward Index
Central And Eastern Europe Risk/Reward Index
Russia Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Table: Russia: Causes Of Mortality (mortality rate per 100,000 population)
Table: Cancer Incidence Rates, 2012-2035
Healthcare Sector
Research & Development
Clinical Trials
Regulatory Development
Intellectual Property Environment
Pricing Regime
Reference Pricing
Medicines Financing
Reimbursement Regime
Protectionist Measures
Competitive Landscape
Pharmaceutical Sector
Research-Based Industry
Table: Multinational Investment In Russia
Generic Drugmakers
Company Developments
Pharmaceutical Retail Sector
Wholesale Sector
Company Profile
Berlin-Chemie/Menarini GmBH
Gedeon Richter
Krka
Lek/Sandoz
Stada AG
Veropharm
Pharmstandard
Demographic Forecast
Table: Population Headline Indicators (Russia 1990-2025)
Table: Key Population Ratios (Russia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Russia 1990-2025)
Table: Population By Age Group (Russia 1990-2025)
Table: Population By Age Group % (Russia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report